Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) Meeting Abstract


Authors: O'Connor, O. A.; Richon, V.; Moskowitz, C. H.; Zelenetz, A. D.; Macgregor-Cortelli, B.; Curly, T.; Richardson, S.; Tong, W.; Rifkind, R.; Marks, P.; O'Brien, J.; Chiao, J.; Scher, H.; Kelly, W.
Abstract Title: Clinical experience of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in heavily pre-treated patients with aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
Meeting Title: 44th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 100
Issue: 11 Pt. 2
Meeting Dates: 2002 Dec 6-10
Meeting Location: Philadelphia, PA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2002-11-01
Start Page: 301B
Language: English
ACCESSION: WOS:000179184801285
PROVIDER: wos
PUBMED: 12448414
Notes: Meeting Abstract: 4742 -- 44th Annual Meeting of the American-Society-of-Hematology -- DEC 06-10, 2002 -- PHILADELPHIA, PENNSYLVANIA -- 2 -- Source: Wos
MSK Authors
  1. William Ping-Yiu Tong
    118 Tong
  2. Craig Moskowitz
    367 Moskowitz
  3. William K Kelly
    106 Kelly
  4. Andrew D Zelenetz
    540 Zelenetz
  5. Howard Scher
    791 Scher
  6. Paul Marks
    138 Marks
  7. Richard Rifkind
    70 Rifkind
Related MSK Work